CryoLife to Present at Two Investor Conferences in September 2017

ATLANTA, Sept. 18, 2017 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced today that Pat Mackin, Chairman, President and Chief Executive Officer, will present at two investor conferences in September 2017.

The first conference is the Cantor Fitzgerald Global Healthcare Conference in New York.

Event: Cantor Fitzgerald Global Healthcare ConferenceDate: Monday, September 25, 2017Time: 4:45 p.m. ET

The second conference is the Ladenburg Thalmann 2017 Healthcare Conference in New York.

Event: Ladenburg Thalmann 2017 Healthcare ConferenceDate: Tuesday, September 26, 2017Time: 9:00 a.m. ET

The live webcast of the Company's presentations can be accessed through CryoLife's website, www.cryolife.com, on the Investor Relations page.  An archived copy of the webcasts will be available for 90 days on the same website.

About CryoLife

Headquartered in suburban Atlanta, Georgia, CryoLife is a leader in the manufacturing, processing, and distribution of implantable living tissues and medical devices used in cardiac and vascular surgical procedures.  CryoLife markets and sells products in more than 80 countries worldwide.  For additional information about CryoLife, visit our website, www.cryolife.com.

View original content with multimedia:http://www.prnewswire.com/news-releases/cryolife-to-present-at-two-investor-conferences-in-september-2017-300520743.html

SOURCE CryoLife, Inc.